Bayer AG is listed in Germany and is a member of the DAX 40 index. According to its Annual Report 2025, Bayer has a 100% free float as defined by Deutsche Börse, private stockholders held some 18% of shares, and it had approximately 566,000 stockholders at the end of 2025. By region, North America held 32.0%, Germany 22.9% and the United Kingdom 14.1%, with 15.1% not covered by the shareholder survey.
The group has three divisions: Pharmaceuticals, Consumer Health and Crop Science. Crop Science, led since January 2022 by Board of Management member Rodrigo Santos, sells corn, soybean, cotton and vegetable seeds and traits, herbicides, fungicides, insecticides and digital agriculture products. It reported 2025 sales of 21.622 billion euros and EBITDA before special items of 4.188 billion euros. Bayer built the division through the purchase of Aventis CropScience in 2001 and Monsanto in 2018. The group had 87,830 employees (full-time equivalents) at 30 June 2026.
In India, Bayer CropScience Limited is listed on BSE (code 506285) and reported revenue from operations of ₹56,750 million for 2025-26. In the United Kingdom, the Crop Science business is based in Cambridge, while Bayer’s UK and Ireland headquarters is in Reading.
